PHF19 is overexpressed in a number of human cancers including prostate cancer [35], glioblastoma, [36, 37], hepatocellular carcinoma [30, 38–40], ovarian cancer [41, 42], melanoma [22, 43], gastric cancer [44–46]. Here, PHF19 is linked to ovarian carcinoma.